PL330797A1 - Derivatives of piperidinacetic acid and their application in treating thrombotic disorders - Google Patents
Derivatives of piperidinacetic acid and their application in treating thrombotic disordersInfo
- Publication number
- PL330797A1 PL330797A1 PL97330797A PL33079797A PL330797A1 PL 330797 A1 PL330797 A1 PL 330797A1 PL 97330797 A PL97330797 A PL 97330797A PL 33079797 A PL33079797 A PL 33079797A PL 330797 A1 PL330797 A1 PL 330797A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- application
- thrombotic disorders
- treating thrombotic
- piperidinacetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
PCT/EP1997/003196 WO1997049699A1 (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
PL330797A1 true PL330797A1 (en) | 1999-06-07 |
Family
ID=27268341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL97330797A PL330797A1 (en) | 1996-06-21 | 1997-06-19 | Derivatives of piperidinacetic acid and their application in treating thrombotic disorders |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0912555A1 (en) |
JP (1) | JP2000512648A (en) |
KR (1) | KR20000022041A (en) |
AP (1) | AP9801417A0 (en) |
AR (1) | AR008245A1 (en) |
AU (1) | AU3261197A (en) |
BR (1) | BR9709930A (en) |
CA (1) | CA2258753A1 (en) |
CZ (1) | CZ424698A3 (en) |
EA (1) | EA199801015A1 (en) |
ID (1) | ID17052A (en) |
IL (1) | IL127464A0 (en) |
IS (1) | IS4924A (en) |
NO (1) | NO985974L (en) |
PL (1) | PL330797A1 (en) |
TR (1) | TR199802665T2 (en) |
WO (1) | WO1997049699A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064215B2 (en) | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
MXPA05008438A (en) * | 2003-02-14 | 2005-10-19 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands. |
CN101432274A (en) | 2006-04-05 | 2009-05-13 | 惠氏公司 | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
CN101578265B (en) | 2007-01-10 | 2013-05-08 | 霍夫曼-拉罗奇有限公司 | Sulfonamide derivatives as chymase inhibitors |
CN113655155A (en) * | 2021-07-28 | 2021-11-16 | 任贤金 | Method for measuring SPH3127 related substances |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
TW221996B (en) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
-
1997
- 1997-06-18 AR ARP970102676A patent/AR008245A1/en unknown
- 1997-06-19 AP APAP/P/1998/001417A patent/AP9801417A0/en unknown
- 1997-06-19 EP EP97928243A patent/EP0912555A1/en not_active Withdrawn
- 1997-06-19 AU AU32611/97A patent/AU3261197A/en not_active Abandoned
- 1997-06-19 IL IL12746497A patent/IL127464A0/en unknown
- 1997-06-19 KR KR1019980710439A patent/KR20000022041A/en not_active Application Discontinuation
- 1997-06-19 ID IDP972092A patent/ID17052A/en unknown
- 1997-06-19 JP JP10502284A patent/JP2000512648A/en active Pending
- 1997-06-19 EA EA199801015A patent/EA199801015A1/en unknown
- 1997-06-19 TR TR1998/02665T patent/TR199802665T2/en unknown
- 1997-06-19 PL PL97330797A patent/PL330797A1/en unknown
- 1997-06-19 WO PCT/EP1997/003196 patent/WO1997049699A1/en not_active Application Discontinuation
- 1997-06-19 CA CA002258753A patent/CA2258753A1/en not_active Abandoned
- 1997-06-19 BR BR9709930A patent/BR9709930A/en not_active Application Discontinuation
- 1997-06-19 CZ CZ984246A patent/CZ424698A3/en unknown
-
1998
- 1998-12-15 IS IS4924A patent/IS4924A/en unknown
- 1998-12-18 NO NO985974A patent/NO985974L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2000512648A (en) | 2000-09-26 |
AP9801417A0 (en) | 1998-12-31 |
NO985974D0 (en) | 1998-12-18 |
BR9709930A (en) | 1999-08-10 |
TR199802665T2 (en) | 1999-03-22 |
CA2258753A1 (en) | 1997-12-31 |
KR20000022041A (en) | 2000-04-25 |
IL127464A0 (en) | 1999-10-28 |
CZ424698A3 (en) | 1999-05-12 |
AU3261197A (en) | 1998-01-14 |
EA199801015A1 (en) | 1999-08-26 |
EP0912555A1 (en) | 1999-05-06 |
AR008245A1 (en) | 1999-12-29 |
WO1997049699A1 (en) | 1997-12-31 |
NO985974L (en) | 1999-02-17 |
IS4924A (en) | 1998-12-15 |
ID17052A (en) | 1997-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
PL331861A1 (en) | Derivatives of propionic acid and their application | |
AU3339897A (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
EP0782399A4 (en) | Hydroxycitric acid concentrate and method of making | |
IL148362A0 (en) | Device for topical treatment of acne and its method of manufacture | |
EP0758196A4 (en) | Compositions and methods of treating tumors | |
US5656608B1 (en) | Amino acid compositions and methods of treatment using same | |
IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
NO970582D0 (en) | Methods and compositions useful in protylaxis and treatment of endotoxin-related conditions | |
GB9507415D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
PL332579A1 (en) | Application of 1-hydroxy-2-pyridinones in treating dermatological infections | |
IL116142A0 (en) | Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis | |
EP1030663A4 (en) | Treatment of fibromyalgia and related disorders | |
PL330797A1 (en) | Derivatives of piperidinacetic acid and their application in treating thrombotic disorders | |
HUP0201299A2 (en) | Device for topical treatment of acne and its method of manufacture | |
PL335688A1 (en) | Novel derivatives of carboxylic acid, method of obtaining them and their application in treating carcinoma | |
AU3261097A (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
PL324929A1 (en) | Cosmetic method of treating and preventing the symptoms of skin ageing | |
EP0835092A4 (en) | Composition and treatment for baldness | |
AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
GB2310318B (en) | Ferroelectric component and method of manufacture | |
GB9609927D0 (en) | Composition and method of treating skin disorders | |
GB9709769D0 (en) | Composition and method of treating skin disorders | |
GB9409641D0 (en) | Composition and method of treating skin disorders |